Last update 20 Mar 2025

Anti-EGFRvIII-directed CAR-T cell therapy(DeHe Biotech (Energae))

Overview

Basic Info

Drug Type
CAR-T
Synonyms-
Target
EGFRvIII
Action
antagonists
Mechanism
EGFRvIII antagonists(Epidermal growth factor receptor variant III antagonists), Gene transference, T lymphocyte replacements
Therapeutic Areas
NeoplasmsNervous System DiseasesDigestive System Disorders+ [1]
Active Indication
GlioblastomaLiver Cancer
Inactive Indication
Esophageal CarcinomaHepatocellular CarcinomaStomach Cancer
Originator Organization
DeHe Biotech Co., LtdDeHe Biotech Co., Ltd
Active Organization
DeHe Biotech Co., LtdDeHe Biotech Co., Ltd
Inactive Organization
Shenzhen Binde Biotechnology Co., Ltd.Shenzhen Binde Biotechnology Co., Ltd.
Drug Highest PhasePhase 2
First Approval Date-
Regulation-
Login to view timeline

Related

100 Clinical Results associated with Anti-EGFRvIII-directed CAR-T cell therapy(DeHe Biotech (Energae))
Login to view more data
100 Translational Medicine associated with Anti-EGFRvIII-directed CAR-T cell therapy(DeHe Biotech (Energae))
Login to view more data
100 Patents (Medical) associated with Anti-EGFRvIII-directed CAR-T cell therapy(DeHe Biotech (Energae))
Login to view more data
100 Deals associated with Anti-EGFRvIII-directed CAR-T cell therapy(DeHe Biotech (Energae))
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
GlioblastomaPhase 2
China
DeHe Biotech Co., LtdDeHe Biotech Co., Ltd
-
Liver CancerPhase 2
China
DeHe Biotech Co., LtdDeHe Biotech Co., Ltd
-
Esophageal CarcinomaDiscovery
China
Shenzhen Binde Biotechnology Co., Ltd.Shenzhen Binde Biotechnology Co., Ltd.
01 Sep 2019
GliomaDiscovery
China
Shenzhen Binde Biotechnology Co., Ltd.Shenzhen Binde Biotechnology Co., Ltd.
01 Sep 2019
Hepatocellular CarcinomaDiscovery
China
Shenzhen Binde Biotechnology Co., Ltd.Shenzhen Binde Biotechnology Co., Ltd.
01 Sep 2019
Stomach CancerDiscovery
China
Shenzhen Binde Biotechnology Co., Ltd.Shenzhen Binde Biotechnology Co., Ltd.
01 Sep 2019
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free